Biblio

Author Title [ Type

] Year

Filters: Author is Liu, Qi-Fa [Clear All Filters]

Journal Article

Yan C-H, Liu Q-F, Wu D-P, Zhang X, Xu L-P, Zhang X-H, Wang Y, Huang H, Bai H, Huang F, et al. Corrigendum to 'Prophylactic donor lymphocyte infusion (DLI) followed by minimal residual disease and graft-versus host disease guided multiple DLIs could improve outcomes after allogeneic hematopoietic stem cell transplantation in patients with refractor. Biol Blood Marrow Transplant. 2019.

Xu L-P, Wang S-Q, Wu D-P, Wang J-M, Gao S-J, Jiang M, Wang C-B, Zhang X, Liu Q-F, Xia L-H, et al. Haplo-identical transplantation for acquired severe aplastic anaemia in a multicentre prospective study. Br J Haematol. 2016.

Xu L-P, Lu D-P, Wu D-P, Jiang E-L, Liu D-H, Huang H, Sun Z-M, Li N-N, Liu Q-F, Zhang X, et al. Hematopoietic stem cell transplantation activity in China 2020-2021 during the SARS-CoV-2 pandemic: a report from the Chinese Blood and Marrow Transplantation Registry Group. Transplant Cell Ther. 2022.

Wang Y, Liu Q-F, Wu D-P, Xu Z-L, Han T-T, Sun Y-Q, Huang F, Fan Z-P, Xu N, Chen F, et al. Mini-dose methotrexate combined with methylprednisolone for the initial treatment of acute GVHD: a multicentre, randomized trial. BMC Med. 2024;22(1):176.

Jia-Bao H, Xin Z, Zi-Wen G, Miao-Miao L, Na X, Fen H, Zhi-Ping F, Li X, Lan D, Shu-Hua L, et al. Ponatinib therapy in recurrent philadelphia chromosome positive central nervous system leukemia with T315I mutation after allo-HSCT. Int J Cancer. 2019.